115 related articles for article (PubMed ID: 4184992)
21. Acute effects of corticosteroids on thyroid activity in Graves' disease.
Williams DE; Chopra IJ; Orgiazzi J; Solomon DH
J Clin Endocrinol Metab; 1975 Aug; 41(2):354-61. PubMed ID: 1174132
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of auto-antibodies to bovine TSH in the serum of two patients with Graves' disease.
Kajita Y; Nakajima Y; Ishida M; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
Acta Endocrinol (Copenh); 1983 Dec; 104(4):423-30. PubMed ID: 6318490
[TBL] [Abstract][Full Text] [Related]
24. [Elevation of IgM and IgG immunoglobulins and ophthalmopathic reaction after intake of triiodothyronine in a thyroidectomized Graves' disease patient. Reversible rupture of the autoimmune equilibrium and the Arthus phenomenon].
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Levin S
Ann Endocrinol (Paris); 1972; 33(1):86-91. PubMed ID: 4266493
[No Abstract] [Full Text] [Related]
25. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
Hall R; Kirkham K; Doniach D; el-Kabir D
Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
[No Abstract] [Full Text] [Related]
26. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Chopra IJ; Chopra U; Orgiazzi J
J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
[No Abstract] [Full Text] [Related]
27. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
28. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
29. [Effect of prednisone in immunosuppressive dosage on the clinical course of eye changes and dynamics of LATS titer in the serum].
Nauman J; Nauman A
Pol Arch Med Wewn; 1973 May; 50(5):449-58. PubMed ID: 4740191
[No Abstract] [Full Text] [Related]
30. Long-acting thyroid stimulator and exophthalmos.
Burke G
Ann Intern Med; 1969 May; 70(5):1045-6. PubMed ID: 4181434
[No Abstract] [Full Text] [Related]
31. [Malignant ophthalmopathy. Results of corticosteroid therapy associated with a cytotoxic immunosuppressive agent].
Aquino CS; Coelho JC; Tendrich M; Gonçalves Filho CA; Pinto JC; Pontes JP
AMB Rev Assoc Med Bras; 1978 Apr; 24(4):115-8. PubMed ID: 308242
[No Abstract] [Full Text] [Related]
32. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
33. Thyroid stimulating immunoglobulin in Graves' disease.
Luttrell BM; Hales IB
Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
[TBL] [Abstract][Full Text] [Related]
34. [On the anti-exophthalmic and anti-thyroid action of an imidazole derivative with trichomonacidal action: metronidazole].
Portioli I; Rocchi F; Maraini G; Pescatori A
Ann Ottalmol Clin Ocul; 1968 Dec; 94(12):1457-73. PubMed ID: 5757142
[No Abstract] [Full Text] [Related]
35. [An antibody called LATS].
Letonturier P; Tourneur R
Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
[No Abstract] [Full Text] [Related]
36. Effect of thyroid ablation on dysthyroid exophthalmos.
Boyle IT; Greig WR; Thomson JA; Winning J; McGirr EM
Proc R Soc Med; 1969 Jan; 62(1):19-23. PubMed ID: 5818232
[No Abstract] [Full Text] [Related]
37. The lipolytic activity of long-acting thyroid stimulator.
Kendall-Taylor P; Munro DS
Biochim Biophys Acta; 1971 Mar; 231(2):314-9. PubMed ID: 5554904
[No Abstract] [Full Text] [Related]
38. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
Wall JR; Good BF; Hetzel BS
Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
[No Abstract] [Full Text] [Related]
39. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
40. [On drug therapy of endocrine ophthalmopathy].
Horster FA; Klein E; Reinwein D
Verh Dtsch Ges Inn Med; 1967; 73():383-6. PubMed ID: 5591782
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
